16:34 EDT Tyra Biosciences (TYRA) files $500M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TYRA:
- Tyra Biosciences reports Q1 EPS (47c), consensus (48c)
- Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
- Tyra Bioscience’s Promising Clinical Developments and Strong Financial Health Justify Buy Rating
- Mitchell Kapoor Issues Buy Rating for Tyra Bioscience Due to TYRA-300’s Potential in NMIBC and ACH Markets
- Tyra Biosciences Advances Precision Medicine Pipeline